Medicare Materials

Your Results

• KHN: Why AstraZeneca and J&J’s Vaccines, In Use Elsewhere, Are Still on Hold in America

  March 01, 2021: By Sarah Jane Tribble The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are Read More >

• KHN: Countless Homebound Patients Still Wait for Covid Vaccine Despite Seniors’ Priority

  February 22, 2021: By Judith Graham Opening another front in the nation’s response to the pandemic, medical centers and other health organizations have begun sending doctors and nurses to apartment buildings and private homes to vaccinate h Read More >

• KHN: As Drug Prices Keep Rising, State Lawmakers Propose Tough New Bills to Curb Them

  February 16, 2021: Fed up with a lack of federal action to lower prescription drug costs, state legislators around the country are pushing bills to penalize drugmakers for unjustified price hikes and to cap payment at much-lower Canadian levels. Read More >

• KHN: When Your Chance for a Covid Shot Comes, Don’t Worry About the Numbers

  February 02, 2021: By Arthur Allen and Liz Szabo When getting vaccinated against covid-19, there’s no sense being picky. You should take the first authorized vaccine that’s offered, experts say. The newest covid vaccine on the horizon, Read More >

• KHN Poll: Nearly Half of American Adults Now Want the Covid Vaccine — ASAP

  January 27, 2021: By Phil Galewitz                   Americans’ reluctance to get vaccinated for covid-19 is waning, according to a poll released Wednesday. Nearly Read More >

• KHN: Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets

  January 07, 2021: Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations. Clark, 57, a former insurance agent Read More >